- Home
- RMCF vs QNCX Comparison
RMCF vs QNCX Comparison
Compare RMCF & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCF | QNCX |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 17.1M |
| IPO Year | 2024 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RMCF | QNCX |
|---|---|---|
| Price | $1.13 | $17.54 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 168.4K | ★ 207.2K |
| Earning Date | 06-16-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.88 | N/A |
| EPS | N/A | ★ 2.88 |
| Revenue | ★ $30,432,352.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.84 | $0.08 |
| 52 Week High | $2.99 | $19.26 |
Technical Indicators
Market Signals| Indicator | RMCF | QNCX |
|---|---|---|
| Relative Strength Index (RSI) | 37.15 | 87.96 |
| Support Level | $0.84 | $0.89 |
| Resistance Level | $1.79 | $19.26 |
| Average True Range (ATR) | 0.18 | 0.81 |
| MACD | 0.02 | 1.29 |
| Stochastic Oscillator | 35.29 | 89.96 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.